Image

Knee Related Subchondral Bone Lesions Treated With IOBP

Knee Related Subchondral Bone Lesions Treated With IOBP

Recruiting
18-60 years
All
Phase N/A

Powered by AI

Overview

The study will be a prospective, multicenter clinical study evaluating clinical and patient reported outcome measures of subjects receiving IOBP® surgical technique using Angel cPRP and BMA processing system to treat subchondral bone pathology (SBP).

Description

The study will be a prospective, multicenter, clinical study, enrolling both male and female patients. Subjects will be identified among the investigators' patient population scheduled for the IOBP® procedure and as being diagnosed with symptomatic SBP that have failed conservative management. IRB approval will be obtained by each participating institution.

The primary outcome measure is adverse event evaluation to determine whether IOBP® can prevent further surgical intervention (i.e., knee replacement surgery, HTO, or calcium phosphate stabilization of SBP) when used to treat symptomatic SBP of the knee.

Eligibility

Inclusion Criteria:

  1. Able to read, understand, sign and complete informed consent
  2. Male or female subject between the ages of 18-60 years
  3. Subject has had pain for greater than three months
  4. Subjects with single SBP in tibia or femur confirmed by minimum 1.5T MRI (including coronal, axial, sagittal, lateral femur, and lateral tibia views) and are candidates for an IOBP® procedure
  5. Subject has stable ligaments
  6. Subject has neutral alignment (max 5° varus or valgus)
  7. Subject has a VAS score greater than or equal to five
  8. Subject is scheduled to undergo surgical intervention using IOBP®

Exclusion Criteria:

  1. Subject has diabetes Type I, Type II uncontrolled, or Type II insulin dependent
  2. Subject has had lower extremity surgery within six months
  3. Subject has had more than two prior surgical procedures in the operative leg
  4. Subject has a neuromuscular condition
  5. Subject has a current infection
  6. Subject has a BMI >35
  7. Subject has subchondral bone collapse or Kellgren Lawrence grade IV osteoarthritis
  8. Subject has joint surface collapse in late stage avascular necrosis
  9. Subject has majority of pain associated with alternate conditions
  10. Subject has had subchondral bone pathology caused by acute trauma
  11. Subject is not neurologically intact.
  12. Subject has history of invasive malignancy (except non-melanoma skin cancer)
  13. Subject that has a planned or scheduled additional surgery within the course of the study (lower extremity)
  14. Subject has an active substance abuse problem
  15. Subject is currently taking narcotic pain medication
  16. Subject is pregnant or planning to become pregnant
  17. Subject is on worker's compensation
  18. Subject has a concomitant procedure not including meniscectomy, synovectomy, chondroplasty, or removal of loose body
  19. Inability to complete study requirements and follow-up visits
  20. Subject that has a bone marrow aspiration that does not meet 60cc

Study details
    Subchondral Cyst

NCT05314608

Arthrex, Inc.

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.